Suppr超能文献

N3-吡啶基吡嗪酮类化合物的合成及构效关系研究作为促肾上腺皮质激素释放因子-1(CRF1)受体拮抗剂。

Synthesis and structure-activity relationships of N3-pyridylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists.

机构信息

Neuroscience Discovery Chemistry, Research and Development, Bristol-Myers Squibb Company, Wallingford, CT 06492, USA.

出版信息

Bioorg Med Chem Lett. 2010 Mar 15;20(6):1890-4. doi: 10.1016/j.bmcl.2010.01.129. Epub 2010 Feb 1.

Abstract

A series of N(3)-pyridylpyrazinones was investigated as corticotropin-releasing factor-1 receptor antagonists. It was observed that the binding affinity of analogues containing a pyridyl group was influenced not only by the substitution pattern on the pyridyl group, but also by the pK(a) of the pyridyl nitrogen. Analogues containing a novel 6-(difluoromethoxy)-2,5-dimethylpyridin-3-amine group were among the most potent N(3)-pyridylpyrazinones synthesized. The synthesis and SAR of N(3)-pyridylpyrazinones is described herein.

摘要

研究了一系列 N(3)-吡啶基吡嗪酮作为促肾上腺皮质激素释放因子-1 受体拮抗剂。结果表明,含有吡啶基的类似物的结合亲和力不仅受到吡啶基取代模式的影响,还受到吡啶氮 pk(a)的影响。含有新型 6-(二氟甲氧基)-2,5-二甲基-3-氨基吡啶基的类似物是合成的最有效 N(3)-吡啶基吡嗪酮之一。本文描述了 N(3)-吡啶基吡嗪酮的合成和 SAR。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验